ORIGINAL ARTICLESOlopatadine inhibits TNFα release from human conjunctival mast cells
REFERENCES (16)
- et al.
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells
Ann Allergy Asthma Immunol
(1997) - et al.
Human lung mast cells release small amounts of interleukin-4 and tumour necrosis factor-alpha in response to stimulation by anti-IgE and stem cell factor
Eur J Pharmacol
(1997) - et al.
Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-α from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells
Invest Ophtalmol Vis Sci
(1998) - et al.
Human conjunctival mast cells (HCMC) release and express message for TNFα in response to anti-IgE challenge in a time and dose dependent manner
J Allergy Clin Immunol
(1999) A multiple comparison procedure for comparing treatments with a control
J Am Stat Assoc
(1955)- et al.
Characterization of ocular anti-allergic and anti-histaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases
J Pharmacol Exp Ther
(1996) - et al.
Activation of eosinophils with cytokines produced by lung mast cells
Int Arch Allergy Immunol
(1997) - et al.
Secretion of proinflammatory cytokines by human conjunctival epithelial cells
Ocular Immunol Inflam
(1997)
There are more references available in the full text version of this article.
Cited by (80)
Etiology and pharmacotherapy of ocular surface allergic diseases
2022, Handbook of Basic and Clinical Ocular Pharmacology and TherapeuticsAntihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis
2015, Allergology InternationalOcular Allergy: Clinical, Therapeutic and Drug Discovery Considerations
2008, Ocular Therapeutics
This work was supported in part by Alcon Labs, Fort Worth, TX, an unrestricted grant from The Society to Prevent Blindness and NIH Grant EY12526.
Copyright © 2000 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.